Literature DB >> 9813002

Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii.

A E Vercesi1, C O Rodrigues, S A Uyemura, L Zhong, S N Moreno.   

Abstract

Respiration, oxidative phosphorylation, and the mitochondrial membrane potential (DeltaPsi) of tachyzoites of the apicomplexan parasite Toxoplasma gondii were assayed in situ using very low concentrations of digitonin to render their plasma membrane permeable to succinate, ADP, safranin O, and other small molecules. The rate of basal respiration was slightly increased by digitonin when the cells were incubated in medium containing succinate. ADP promoted an oligomycin-sensitive transition from resting to phosphorylating respiration. Respiration was sensitive to antimycin A and cyanide, and N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) was oxidized by antimycin A-poisoned mitochondria. The addition of ADP after TMPD/ascorbate also resulted in phosphorylating respiration. The antitoxoplasmosis drug atovaquone, at a very low concentration (0.03 microM), totally inhibited respiration and disrupted the mitochondrial membrane potential. Atovaquone was shown to inhibit the respiratory chain of T. gondii and mammalian mitochondria between cytochrome b and c1 as occurs with antimycin A1. Phosphorylation of ADP could not be obtained in permeabilized tachyzoites in the presence of either pyruvate, 3-oxo-glutarate, glutamate, isocitrate, dihydroorotate, alpha-glycerophosphate, or endogenous substrates. Although ADP phosphorylation was detected in the presence of malate, this activity was rotenone-insensitive and was probably due to the conversion of malate into succinate through a fumarate reductase activity that was detected in mitochondrial extracts. Together these results provide the first direct biochemical evidence that the respiratory chain and oxidative phosphorylation are functional in apicomplexan parasites, although the terminal respiratory pathway is different from that in the mammalian host.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813002     DOI: 10.1074/jbc.273.47.31040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Classical and alternative components of the mitochondrial respiratory chain in pathogenic fungi as potential therapeutic targets.

Authors:  Vicente de Paulo Martins; Taisa Magnani Dinamarco; Carlos Curti; Sérgio Akira Uyemura
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Dynamics of Toxoplasma gondii differentiation.

Authors:  Florence Dzierszinski; Manami Nishi; Lillian Ouko; David S Roos
Journal:  Eukaryot Cell       Date:  2004-08

3.  Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.

Authors:  Christopher P Hencken; Lorraine Jones-Brando; Claudia Bordón; Remo Stohler; Bryan T Mott; Robert Yolken; Gary H Posner; Lauren E Woodard
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

4.  Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites.

Authors:  P Holland Alday; Erin V McConnell; Jan M Boitz Zarella; Rozalia A Dodean; Papireddy Kancharla; Jane X Kelly; J Stone Doggett
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

5.  A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion.

Authors:  Tomoya Saito; Manami Nishi; Muoy I Lim; Bo Wu; Takuya Maeda; Hisayuki Hashimoto; Tsutomu Takeuchi; David S Roos; Takashi Asai
Journal:  J Biol Chem       Date:  2008-03-06       Impact factor: 5.157

6.  Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner.

Authors:  Hany M Ibrahim; Hiroshi Bannai; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

7.  Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii.

Authors:  Richard Nitzsche; Vyacheslav Zagoriy; Richard Lucius; Nishith Gupta
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

8.  Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii.

Authors:  San San Lin; Uwe Gross; Wolfgang Bohne
Journal:  Eukaryot Cell       Date:  2009-03-13

9.  Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii.

Authors:  James I MacRae; Lilach Sheiner; Amsha Nahid; Christopher Tonkin; Boris Striepen; Malcolm J McConville
Journal:  Cell Host Microbe       Date:  2012-11-15       Impact factor: 21.023

10.  Effects of Neospora caninum infection on brain microvascular endothelial cells bioenergetics.

Authors:  Hany M Elsheikha; Charlotte L McKinlay; Nashwa A Elsaied; Paul A Smith
Journal:  Parasit Vectors       Date:  2013-01-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.